CLINICAL_TRIALS
trial_result
· 2023-03-02
Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) Treatment for Alzheimer Patients [Phase 2]
Summary
A Phase 2 clinical trial evaluating transcranial magnetic stimulation (TMS) for Alzheimer disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hadassah Medical Organization | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED